- Trials with a EudraCT protocol (107)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
107 result(s) found for: Epithelium.
Displaying page 1 of 6.
EudraCT Number: 2005-001722-92 | Sponsor Protocol Number: 1 | Start Date*: 2005-10-12 |
Sponsor Name:The Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery | ||
Full Title: Systemic Bevacizumab (Avastin®) Therapy for Exudative Neovascular Age-Related Macular Degeneration (BEAT-AMD-Study) | ||
Medical condition: Age related macular degeneration (AMD) patients with fibrovascular pigment epithelium detachment (PED), subfoveal choroidal neovascularisations (CNV) extending under the geometric center of the fov... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002845-23 | Sponsor Protocol Number: CCD-GPLSCD01-03 | Start Date*: 2015-12-16 | |||||||||||
Sponsor Name:Holostem Terapie Avanzate s.r.l. | |||||||||||||
Full Title: Multinational, multicentre, prospective, open-label, uncontrolled clinical trial to assess the efficacy and safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for restoratio... | |||||||||||||
Medical condition: corneal lesions with associated moderate to severe limbal stem cell deficiency due to ocular burns | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) BE (Ongoing) NL (Ongoing) FR (Completed) PL (Completed) ES (Ongoing) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001344-11 | Sponsor Protocol Number: CCD-GPLSCD01-03-FU | Start Date*: 2018-04-11 | |||||||||||
Sponsor Name:Chiesi Farmaceutici S.p.A. | |||||||||||||
Full Title: Multinational, multicenter, prospective, long-term safety and efficacy follow-up study after Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for restoration of corneal epithelium i... | |||||||||||||
Medical condition: corneal lesions with associated moderate to severe limbal stem cell deficiency due to ocular burns | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) PL (Completed) FR (Completed) DE (Completed) GB (GB - no longer in EU/EEA) ES (Ongoing) NL (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002384-15 | Sponsor Protocol Number: 3.0 | Start Date*: 2014-10-23 | ||||||||||||||||||||||||||
Sponsor Name:Universitätsklinik für Augenheilkunde und Optometrie | ||||||||||||||||||||||||||||
Full Title: Intravitreal Aflibercept treatment in RAP-Lesions, PED, hemorrhagic CNV and PCV | ||||||||||||||||||||||||||||
Medical condition: Exsudative Maculopathies | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-005787-42 | Sponsor Protocol Number: ITFE-2092-C1 | Start Date*: 2016-08-10 | |||||||||||
Sponsor Name:ITF Research Pharma SLU | |||||||||||||
Full Title: A Phase 2, Dose-ranging, 12-week, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (... | |||||||||||||
Medical condition: Vulvovaginal atrophy in postmenopausal women | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) CZ (Completed) HU (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000598-30 | Sponsor Protocol Number: CS001-EU01 | Start Date*: 2012-03-06 | |||||||||||
Sponsor Name:Cellseed France S.A.R.L. | |||||||||||||
Full Title: MULTICENTER STUDY OF CULTURED AUTOLOGOUS ORAL MUCOSAL EPITHELIAL CELL-SHEET (CAOMECS) TRANSPLANTATION TO PATIENTS WITH TOTAL LIMBAL STEM CELL DEFICIENCY | |||||||||||||
Medical condition: Limbal Stem Cell Deficiency of the Eye | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) ES (Ongoing) AT (Prematurely Ended) PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003215-63 | Sponsor Protocol Number: 69HCL19_0032 | Start Date*: 2020-03-10 | |||||||||||
Sponsor Name:Hospices Civils de Lyon - Direction de la Recherche Clinique et de l'Innovation | |||||||||||||
Full Title: Cultured Autologous Oral Mucosa Epithelial sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency - FEMJA for « Feuillet Epithélial de Muqueuse Jugale Autologue » | |||||||||||||
Medical condition: Bilateral Limbal Stem Cell Deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008259-41 | Sponsor Protocol Number: OZR-2008-20 | Start Date*: 2009-03-30 |
Sponsor Name:Rotterdam Eye Hospital | ||
Full Title: Anti-VEGF (bevacizumab/ranibizumab) versus RPE-choroid graft in the treatment of 1) non-responders to 3 intravitreal anti-VEGF injections, or 2) patients with AMD and pigment epithelium rip, or 3) ... | ||
Medical condition: Age related macular degeneration and either of the following conditions: 1) not responding to 3 intravitreal anti-VEGF injections, or 2) pigment epithelium rip, or 3) massive haemorrhage. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016613-22 | Sponsor Protocol Number: OxyPeP-001 | Start Date*: 2010-06-14 | |||||||||||
Sponsor Name:PeP-Tonic Medical AB | |||||||||||||
Full Title: A double-blind, placebo controlled multi-centre study to evaluate the effects of topical Oxytocin on vaginal atrophy in postmenopausal women. | |||||||||||||
Medical condition: Vaginal atrophy in postmenopausal women | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000361-78 | Sponsor Protocol Number: HTA-HUR-01 | Start Date*: 2020-12-01 |
Sponsor Name:HOLOSTEM TERAPIE AVANZATE S.R.L. | ||
Full Title: PROSPECTIVE, OPEN-LABEL, UNCONTROLLED CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF AUTOLOGOUS CULTURED ORAL MUCOSA GRAFTS FOR URETHRAL RECONSTRUCTION IN PATIENTS DUE TO HYPOSPADIAS TREATMENT... | ||
Medical condition: Urethral reconstruction in patients due to hypospadias treatment failure. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003768-31 | Sponsor Protocol Number: NNF18OC0052256 | Start Date*: 2019-12-05 |
Sponsor Name:Lungemedicinsk Forskningsenhed | ||
Full Title: Effects of azithromycin treatment on anti-viral immunity in patients with asthma and COPD. | ||
Medical condition: COPD and asthma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001563-12 | Sponsor Protocol Number: 20142017 | Start Date*: 2015-02-16 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Efficacy of Single inhaler Maintenance And Reliever Therapy (SMART) with Spiromax® budesonide/formoterol versus fixed dose treatment with Diskus® fluticasone/salmeterol in COPD | ||
Medical condition: Chronic obstructive pulmonary disease (COPD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005462-12 | Sponsor Protocol Number: LUTA1 | Start Date*: 2007-12-11 |
Sponsor Name:St. Eriks Eye Hospital | ||
Full Title: A prospective, randomized, masked and controlled trial of intravitreal ranibizumab (Lucentis®) combined with transpupillary thermotherapy (TTT) in patients with neovascular age-related macular dege... | ||
Medical condition: Age-related macular degeneration (AMD) is the leading cause of visual impairment and social blindness in people 60 years or older. Approximately 80% of patients with severe visual loss exhibit neov... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001183-37 | Sponsor Protocol Number: n.a. | Start Date*: 2008-06-02 |
Sponsor Name:Erasmus MC | ||
Full Title: PROSPECTIVE RANDOMIZED COMPARISON OF EMR VERSUS EMR FOLLOWED BY PHOTODYNAMIC THERAPY FOR THE TREATMENT OF EARLY BARRETT’S CANCER | ||
Medical condition: high grade dysplasia and early carcinoma in Barrett Esophagus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001259-11 | Sponsor Protocol Number: 80-83600-98-10006 | Start Date*: 2013-12-19 |
Sponsor Name:Zon MW | ||
Full Title: Tacrolimus suppositories versus beclomethason suppositories for the treatment of proctitis refractory to local 5-ASA. | ||
Medical condition: Refractory and/of recurrent ulcerative proctitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002349-40 | Sponsor Protocol Number: CRTH258A2303E1 | Start Date*: 2020-11-17 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A 56-week phase IIIb/IV, open-label, one-arm extension study to assess the efficacy and safety of brolucizumab 6mg in a Treat-to-Control regimen with maximum treatment intervals up to 20 weeks for ... | |||||||||||||
Medical condition: neovascular Age-related Macular Degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) PT (Completed) CZ (Completed) SE (Completed) BE (Completed) DE (Completed) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001458-10 | Sponsor Protocol Number: RN1002-0028 | Start Date*: 2004-12-21 | |||||||||||
Sponsor Name:Renovo Ltd | |||||||||||||
Full Title: A single site, placebo and standard-care controlled, double blind, randomised trial to investigate the efficacy of four doses of RN1002 in accelerating early wound healing of punch biopsy wounds | |||||||||||||
Medical condition: Wound Healing | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001200-36 | Sponsor Protocol Number: AVA001 | Start Date*: 2006-09-18 |
Sponsor Name:St. Eriks Eye Hospital [...] | ||
Full Title: A prospective, randomized, masked and controlled trial of intravitreal bevacizumab (Avastin) versus verteporfin photodynamic therapy (PDT) in patients with neovascular age-related macular degenera... | ||
Medical condition: Age-related macular degeneration (AMD) is the leading cause of visual impairment and social blindness in people 60 years or older. Approximately 75% of patients with severe visual loss exhibit ne... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000275-14 | Sponsor Protocol Number: GB29260 | Start Date*: 2014-08-07 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A Phase II, randomized, double-blind, placebo-controlled bronchoscopy study to evaluate the effects of Lebrikizumab on airway eosinophilic inflammation in patients with uncontrolled asthma on inhal... | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) IE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000608-16 | Sponsor Protocol Number: 5466 | Start Date*: 2011-12-21 |
Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust [...] | ||
Full Title: To evaluate the safety and effectiveness of human ex vivo expanded autologous limbal stem cells for the treatment of unilateral total limbal stem cell deficiency | ||
Medical condition: unilateral total limbal stem cell deficiency | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.